SMAD3 and Myocardial fibrosis: In addition, Smad3 is pathogenic in cardiovascular diseases, and its overexpression could lead to myocardial inflammation, myocardial fibrosis, and insulin synthesis and secretion disorders, which is a key mediator in the pathogenesis of DCM.